390 participants
A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-09-19
- Start Date:
- 2025-07-18
- Completion:
- 2029-06-30
Conditions
- Recurrent and Refractory Diffuse Large B-cell Lymphoma
Interventions
- DRUG
No Results Yet